Background Cardiovascular diseases (CVD) impact a substantial portion of the global
population and represent a significant threat to experiencing life‐threatening outcomes …

Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …

Almost a third of all fatalities may be attributed to cardiovascular disease (CVD), making it a
primary cause of mortalities worldwide. Better diagnostic tools and secure, non-invasive …

Cardiovascular disease (CVD), which encompasses a number of conditions that can affect
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …

Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic
diseases in the 21st century, with a high mortality rate. This review summarizes the various …

Cardiovascular diseases (CVDs) are the leading cause of death around the world, a trend
that will progressively grow over the next decade. Recently, with the advancement of …

Worldwide, cardiovascular diseases (CVDs) account for the vast majority of deaths and
place enormous financial strains on healthcare systems. Gold nanoparticles, quantum dots …

Nanomedicine has become an important tool in the imaging and therapy of numerous
diseases. This is due, in large part, to the ability to generate multifunctional nanoagents …

Cardiovascular diseases (CVDs) are known as life-threatening illnessescaused by severe
abnormalities in the cardiovascular system. They are a leading cause of mortality and …

Cardiovascular diseases (CVDs) present a significant threat to health, with traditional
pharmaceuticals for their treatment being hindered by inefficiencies due to non-targeted …